Advances in the Treatment of Testicular Cancer
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 66 (5) , 641-659
- https://doi.org/10.2165/00003495-200666050-00005
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Chemotherapie bei Keimzelltumoren mit intermediärer und schlechter PrognoseDer Onkologe, 2003
- RPLND or Primary Chemotherapy in Clinical Stage IIA/B Nonseminomatous Germ Cell Tumors?European Urology, 2000
- The international germ cell consensus classification: A new prognostic factor-based staging classification for metastatic germ cell tumoursClinical Oncology, 1997
- Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage ISupportive Care in Cancer, 1996
- Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancerEuropean Journal Of Cancer, 1995
- The Role of Retroperitoneal Lymphadenectomy in Clinical Stage B Testis Cancer: The Indiana University Experience (1965 to 1989)Journal of Urology, 1995
- Secondary Leukemia Associated With a Conventional Dose of Etoposide: Review of Serial Germ Cell Tumor ProtocolsJNCI Journal of the National Cancer Institute, 1993
- The activity of single-agent carboplatin in advanced seminomaEuropean Journal Of Cancer, 1992
- Immediate Adjuvant Chemotherapy versus Observation with Treatment at Relapse in Pathological Stage II Testicular CancerNew England Journal of Medicine, 1987
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987